Navigation Links
Kendle Announces Departure of Senior Vice President and CFO Karl 'Buzz' Brenkert III; Appoints Keith A. Cheesman as Successor

CINCINNATI, April 28 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Karl "Buzz" Brenkert III, Senior Vice President, Chief Financial Officer (CFO) and Secretary, will depart the Company effective May 6, 2009. Brenkert has served as CFO of the Company since January 2003. Succeeding Brenkert as Senior Vice President and CFO is Keith A. Cheesman, Vice President, Accounting and a current member of Kendle's Finance senior management team. As CFO Cheesman will oversee the Company's global financial operations, including Finance, Accounting, Budgeting, Tax, Investor Relations and Financial Planning.

(Logo: )

"We extend our appreciation to Buzz for his service to Kendle and wish him well," said Candace Kendle, PharmD, Chairman and Chief Executive Officer. She continued, "We are pleased to appoint Keith as CFO and look forward to his expanded role as part of our executive team."

Cheesman brings 28 years of experience in corporate finance and accounting management to the CFO role, including previous experience as Vice President, Finance; Chief Financial Officer; and Treasurer for a publicly traded site management organization. Cheesman has served as a member of Kendle's Finance senior management team from 2000 to 2004 and from January 2008 to present and has provided leadership for nearly all facets of the Company's financial operations. From 2004 to 2008 he broadened his experience by serving as Vice President - Corporate Controller and a member of the senior management team for Ohio Casualty Corporation, a publicly traded U.S. property and casualty insurance provider with $1.5 billion in annual premiums and 2,100 employees across 20 U.S. locations. Cheesman rejoined Kendle in January 2008, assuming expanded leadership responsibilities as Vice President, Accounting responsible for the Company's Accounting, Tax, Project Financial Support and Internal Audit functions.

Cheesman holds a Bachelor of Science in accounting from University of Dayton. He is a member of the American Institute of Certified Public Accountants, Ohio Society of Certified Public Accountants and Financial Executives International.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle to Host Conference Call to Discuss Revised 2009 Outlook
2. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
3. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
5. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
6. Kendle to Present at the 2008 Credit Suisse Health Care Conference
7. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
8. Kendle Named a Best Place to Work in Greater Cincinnati
9. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
10. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
11. Kendle to Present at the UBS Global Life Sciences Conference
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
Breaking Biology Technology:
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):